Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
41m agoNayax to Report 2026 Q1 Earnings on May 12, 2026
1h agoCC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
1h agoCanadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
1h agoWaraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
1h agoSierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine

Allergy Therapeutics

About

Allergy Therapeutics (LSE:AGY) — investor relations, events, news, and company updates on 6ix.

Latest News

Mar 31 2026
Interim Results for six months ended 31 Dec 2025
Mar 12 2026
PDMR Dealings & Shareholding Update
Mar 4 2026
Positive Biomarker Results from PROTECT Trial
Feb 26 2026
Allergy Therapeutics presents progress at AAAAI
Feb 23 2026
Update on funding and total voting rights

Financials

Revenue
GBX57.29 M
Market Cap
GBX652.25 M
EPS
-0.01

Community Chat

Ask AI

6ix6ixAIEvents